Publications by authors named "Maryam Dehabeh"

Article Synopsis
  • Curcumin supplementation (500 mg/day for 8 weeks) was tested in a clinical trial with 72 patients recovering from acute myocardial infarction to see if it could help reduce heart injury.
  • Results showed significant improvements in glycemic control (lower HbA1C), lipid profiles (reduced LDL and improved HDL), and liver enzymes in the curcumin group compared to the placebo group, though ejection fraction and other cardiac markers remained unchanged.
  • The study concludes that while curcumin positively affected metabolic markers, it did not significantly impact heart function post-AMI.
View Article and Find Full Text PDF

Background: Experimental and clinical studies have revealed that curcumin may be an effective therapy for non-alcoholic fatty liver disease (NAFLD). Hence, the aim of this study was to assess the effect of curcumin plus piperine administration on NAFLD.

Methods: Adults 18-65 years-old diagnosed with NAFLD by liver sonography were randomly allocated to curcumin (500 mg/day) or placebo groups for 2 months.

View Article and Find Full Text PDF

Non-alcoholic fatty liver disease (NAFLD) is a global health problem with increasing prevalence among overweight and obese patients. It is strongly associated with conditions of insulin resistance including type 2 diabetes mellitus (T2DM) and obesity. It has detrimental consequences ranged from simple steatosis to irreversible hepatic fibrosis and cirrhosis.

View Article and Find Full Text PDF

Scientists proposed that curcumin could be used for treatment of non-alcoholic fatty liver disease (NAFLD). In this article, we aimed to identify the effect of curcumin on NAFLD improvement. Fifty patients with NAFLD, were divided into two groups in this randomized, double-blind, and controlled clinical trial.

View Article and Find Full Text PDF

Background/objectives: Curcumin, a natural polyphenol compound in the spice turmeric, has been found to have potent anti-oxidative and anti-inflammatory activity. Curcumin may treat non-alcoholic fatty liver disease (NAFLD) through its beneficial effects on biomarkers of oxidative stress (OS) and inflammation, which are considered as two feature of this disease. However, the effects of curcumin on NAFLD have been remained poorly understood.

View Article and Find Full Text PDF